FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE

Monomethyl and monoethyl fumarate prodrugs, pharmaceutical compositions comprising the monomethyl and monoethyl fumarate prodrugs, and methods of using monomethyl and monoethyl fumarate prodrugs and pharmaceutical compositions for treating neurodegenerative, inflammatory, and autoimmune disorders in...

Full description

Saved in:
Bibliographic Details
Main Authors SCHEUERMAN, RANDALL A, MANTHATI, SURESH K, RAILLARD, STEPHEN P
Format Patent
LanguageEnglish
French
Published 21.04.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Monomethyl and monoethyl fumarate prodrugs, pharmaceutical compositions comprising the monomethyl and monoethyl fumarate prodrugs, and methods of using monomethyl and monoethyl fumarate prodrugs and pharmaceutical compositions for treating neurodegenerative, inflammatory, and autoimmune disorders including multiple sclerosis, psoriasis, irritable bowel disorder, ulcerative colitis, arthritis, chronic obstructive pulmonary disease, asthma, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are disclosed. La présente invention concerne des promédicaments de fumarate de monométhyle et de monoéthyle, des compositions pharmaceutiques contenant ces promédicaments de fumarate de monométhyle et de monoéthyle et des promédicaments de fumarate de monoéthyle et des compositions pharmaceutiques pour traiter des troubles neurodégénératifs, inflammatoires et auto-immuns, tels que la sclérose en plaques, le psoriasis, le syndrome du côlon irritable, la rectocolite hémorragique, l'arthrite, la bronchopneumopathie obstructive chronique, l'asthme, la maladie de Parkinson, la maladie de Huntington et la sclérose latérale amyotrophique.
Bibliography:Application Number: WO2015US55803